Jerome Barakos

Author PubWeight™ 22.74^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study.	Lancet Neurol	2010	5.03
2	Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis.	Lancet Neurol	2012	2.75
3	Subfield atrophy pattern in temporal lobe epilepsy with and without mesial sclerosis detected by high-resolution MRI at 4 Tesla: preliminary results.	Epilepsia	2009	1.33
4	Brain atrophy in long-term abstinent alcoholics who demonstrate impairment on a simulated gambling task.	Neuroimage	2006	1.18
5	Prevalence of asymptomatic vasogenic edema in pretreatment Alzheimer's disease study cohorts from phase 3 trials of semagacestat and solanezumab.	Alzheimers Dement	2011	1.13
6	Involvement of the thalamocortical network in TLE with and without mesiotemporal sclerosis.	Epilepsia	2009	1.10
7	Parietal gray matter volume loss is related to spatial processing deficits in long-term abstinent alcoholic men.	Alcohol Clin Exp Res	2009	1.05
8	Statistical parametric mapping of brain morphology: sensitivity is dramatically increased by using brain-extracted images as inputs.	Neuroimage	2006	0.98
9	Controlling for premorbid brain size in imaging studies: T1-derived cranium scaling factor vs. T2-derived intracranial vault volume.	Psychiatry Res	2004	0.97
10	Neuroanatomy and volumes of brain structures of a live California sea lion (Zalophus californianus) from magnetic resonance images.	Anat Rec (Hoboken)	2009	0.95
11	Increased white matter signal hyperintensities in long-term abstinent alcoholics compared with nonalcoholic controls.	Alcohol Clin Exp Res	2008	0.92
12	Age-related gray matter shrinkage in a treatment naïve actively drinking alcohol-dependent sample.	Alcohol Clin Exp Res	2009	0.87
13	Amyloid PET Screening for Enrichment of Early-Stage Alzheimer Disease Clinical Trials: Experience in a Phase 1b Clinical Trial.	Alzheimer Dis Assoc Disord	2016	0.85
14	Widespread extrahippocampal NAA/(Cr+Cho) abnormalities in TLE with and without mesial temporal sclerosis.	J Neurol	2010	0.85
15	Magnetic resonance imaging quality and volumes of brain structures from live and postmortem imaging of California sea lions with clinical signs of domoic acid toxicosis.	Dis Aquat Organ	2010	0.81
16	A two-level multimodality imaging Bayesian network approach for classification of partial epilepsy: preliminary data.	Neuroimage	2013	0.75
17	Presumed bilateral lateral geniculate nuclei ischemia.	AJNR Am J Neuroradiol	2006	0.75
18	Re: Treatment of a splenic artery aneurysm with use of a stent-graft.	J Vasc Interv Radiol	2002	0.75